(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PHARMACO-NET

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

PHARMACO-NET

ST13

US500000097646979

Class

42

Filing

97646979

Registration

8182558

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

56

Latest update

03/25/2026

Trademark type

Combined

Nice classes

42

Filing date

10/25/2022

Registration date

03/24/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/24/2026

Last transaction

03/25/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

Drawing code

3

Owner type

03

Owner location

Daejeon, KR

Examiner

MCNAMARA, SHANA MARIE

Law office

N70

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the stylized word "PHARMACO-NET" with a large capital "P". To the left of the word is a circuit pattern.

Holders and representatives

Holders

Calici Co., Ltd.

Representatives

Leigh Ann Lindquist Sughrue Mion, PLLC

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Advisory services related to the research and development of pharmaceuticals; consultancy in the field of research and development of pharmaceutical and medical products; advisory services in the field of research and development of pharmaceutical products; consultancy and information services provided via the internet relating to research and development of pharmaceutical products; consultancy and information services relating to research and development of pharmaceutical products; consultancy and information services relating to biopharmaceutical products

Publications

History of USPTO decisions and trademark events.

56 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

03/24/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

03/24/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/03/2026

PUBO

PUBLISHED FOR OPPOSITION

02/03/2026

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/28/2026

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

01/09/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/30/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

12/30/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

12/30/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

12/30/2025

CNEA

EXAMINERS AMENDMENT -WRITTEN

12/30/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/13/2025

GNRT

NON-FINAL ACTION E-MAILED

09/13/2025

CNRT

NON-FINAL ACTION WRITTEN

09/13/2025

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

09/13/2025

OTHE

CASE RETURNED TO EXAMINATION

09/03/2025

IUCN

NOTICE OF ALLOWANCE CANCELLED

09/03/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/11/2025

GNRT

NON-FINAL ACTION E-MAILED

08/11/2025

CNRT

SU - NON-FINAL ACTION - WRITTEN

08/11/2025

JURT

JURISDICTION RESTORED TO EXAMINING ATTORNEY

07/28/2025

PCBG

PETITION TO DIRECTOR - CHANGE BASIS - GRANTED

07/28/2025

APET

ASSIGNED TO PETITION STAFF

07/28/2025

TPAD

TEAS PETITION TO AMEND BASIS RECEIVED

06/09/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/12/2025

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

05/12/2025

EWOR

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

05/12/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/12/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/12/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

05/12/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

05/12/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/06/2025

EX2G

SOU EXTENSION 2 GRANTED

03/05/2025

EXT2

SOU EXTENSION 2 FILED

03/05/2025

EEXT

SOU TEAS EXTENSION RECEIVED

03/05/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/04/2024

EX1G

SOU EXTENSION 1 GRANTED

09/04/2024

EXT1

SOU EXTENSION 1 FILED

09/04/2024

EEXT

SOU TEAS EXTENSION RECEIVED

09/04/2024

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

04/30/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

03/05/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/09/2024

PUBO

PUBLISHED FOR OPPOSITION

01/09/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/20/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/05/2023

DOCK

ASSIGNED TO EXAMINER

11/06/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/03/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/03/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/03/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/12/2023

GNRT

NON-FINAL ACTION E-MAILED

08/12/2023

CNRT

NON-FINAL ACTION WRITTEN

08/12/2023

DOCK

ASSIGNED TO EXAMINER

08/08/2023

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

11/09/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/08/2022

NWAP

NEW APPLICATION ENTERED

10/28/2022

Continuous trademark protection

Get notified about every new filing that threatens PHARMACO-NET or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.